Veloxis Pharmaceuticals
NC - CaryPharmaceutical
Focus: Veloxis is a specialty pharmaceutical company focused on immunosuppression therapies for transplant patients, headquartered in Cary, NC with 5,000+ employees. The company's portfolio is dominated by ENVARSUS XR, a once-daily tacrolimus formulation for organ transplantation.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
5000+
Open Jobs
0
About Veloxis Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Veloxis Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
1 in 5yr
ENVARSUS XR
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$13M Part DDeclining
LOE Approaching
Help build intelligence for Veloxis Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.